Dr. Jose Ortiz, M.D.,F.A.C.E.
What this data tells you about Dr. Ortiz
Dr. Jose Ortiz is an endocrinology in Beaumont, TX, with 19 years in practice. Based on federal Medicare data, Dr. Ortiz performed 33,778 Medicare services across 9,199 unique beneficiaries.
Between the years covered by Open Payments, Dr. Ortiz received a total of $18,251 from 49 pharmaceutical and/or device companies across 1139 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in endocrinology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Ortiz is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Denosumab injection (Prolia/Xgeva) | 16,620 | $18 | $44 |
| Blood draw (venipuncture) | 1,403 | $8 | $15 |
| Blood creatinine level | 1,125 | $5 | $25 |
| Urea nitrogen level to assess kidney function, quantitative | 1,124 | $4 | $25 |
| Blood potassium level | 1,059 | $5 | $25 |
| Liver function blood test panel | 965 | $8 | $50 |
| Calcium level, total | 952 | $5 | $25 |
| Lipid panel (cholesterol and triglycerides) | 938 | $13 | $85 |
| Hemoglobin A1c test (diabetes monitoring) | 929 | $10 | $50 |
| Thyroid stimulating hormone (TSH) test | 866 | $16 | $70 |
| Blood glucose (sugar) level | 844 | $4 | $25 |
| Office visit, established patient, complex (40-54 min) | 807 | $120 | $220 |
| Free thyroxine (T4) test | 772 | $9 | $70 |
| Parathyroid hormone level test | 767 | $40 | $122 |
| Office visit, established patient (30-39 min) | 679 | $86 | $195 |
| Prolonged office or other outpatient evaluation and management service(s) beyond the maximum required time of the primary procedure which has been selected using total time on the date of the primary service; each additional 15 minutes by the physician or | 496 | $24 | $50 |
| Vitamin D level test | 480 | $29 | $125 |
| Office visit, established patient (20-29 min) | 381 | $61 | $130 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with interpretation and report | 377 | $25 | $75 |
| Creatinine test (kidney function) | 353 | $5 | $50 |
| Drug injection, under skin or into muscle | 334 | $10 | $30 |
| Urine microalbumin test (kidney screening) | 325 | $6 | $50 |
| Albumin (protein) level | 210 | $5 | $20 |
| Bone density scan (DEXA) | 208 | $35 | $294 |
| Ultrasound scan of head and neck soft tissue | 204 | $76 | $450 |
| Vitamin B-12 level test | 201 | $15 | $65 |
| Thyroid hormone, t3 measurement, free | 117 | $17 | $88 |
| New patient office visit, complex (60-74 min) | 78 | $155 | $350 |
| Continuous monitoring of blood sugar level in tissue fluid using sensor under skin with provider supplied equipment | 51 | $91 | $400 |
| Urine calcium level | 31 | $6 | $35 |
| Testosterone (hormone) level, total | 27 | $25 | $112 |
| New patient office visit (45-59 min) | 22 | $111 | $325 |
| Fine needle aspiration biopsy using ultrasound guidance, first growth | 19 | $102 | $575 |
| Electrocardiogram (EKG), 12-lead | 14 | $9 | $89 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (95%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Ortiz is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Ortiz experienced with denosumab injection (prolia/xgeva)?
Does Dr. Ortiz receive payments from pharmaceutical companies?
How do Dr. Ortiz's costs compare to other endocrinologys in Beaumont?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology